购物车
- 全部删除
- 您的购物车当前为空
Miriplatin hydrate (SM-11355 (hydrate)) (MPT)是一种用于TACE 的新型铂类化合物,在肝细胞癌(HCC)的治疗中显示出良好的前景。米铂是一种亲脂性铂复合物,容易悬浮在碘油中,并在肿瘤组织中逐渐释放活性铂化合物。
Miriplatin hydrate (SM-11355 (hydrate)) (MPT)是一种用于TACE 的新型铂类化合物,在肝细胞癌(HCC)的治疗中显示出良好的前景。米铂是一种亲脂性铂复合物,容易悬浮在碘油中,并在肿瘤组织中逐渐释放活性铂化合物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 238 | 现货 | |
5 mg | ¥ 563 | 现货 | |
10 mg | ¥ 708 | 现货 | |
25 mg | ¥ 1,370 | 现货 | |
50 mg | ¥ 2,160 | 现货 | |
100 mg | ¥ 3,110 | 现货 | |
200 mg | ¥ 4,380 | 现货 |
产品描述 | Miriplatin hydrate (SM-11355 (hydrate)) (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC). Miriplatin hydrate is a lipophilic platinum complex that can be easily suspended in Lipiodol and gradually releases active platinum compounds in tumor tissue. |
别名 | SM-11355 (hydrate), 米铂水合物, Miripla, Miriplatin, SM 11355, SM11355, SM-11355, Miriplatin hydrate |
分子量 | 782.01 |
分子式 | C34H70N2O5Pt |
CAS No. | 250159-48-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | H2O: Insoluble DMSO: < 1 mg/mL (insoluble), DMSO inactivates the activity of Miriplatin. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.